Breaking News

FSSAI Suspends License of Rehaan Healthcare Over Severe Food Safety Violations

The Food Safety and Standards Authority of India (FSSAI) has suspended the manufacturing license of Rehaan Healthcare with immediate effect following critical non-compliances discovered during an inspection of its Health Supplements...

From Laboratory to Patients: ICMR’s Indigenous Biomedical Technologies Move Towards Commercialization

In a significant milestone for India's biomedical innovation ecosystem, the Indian Council of Medical Research (ICMR) has formally...

CISCE Makes Health and Physical Education Compulsory for Classes 9 to 12 Under NEP 2020

The Council for the Indian School Certificate Examinations (CISCE) has announced that Health and Physical Education is now...

Momentis Surgical’s Anovo Robotic System Gets FDA Approval for Multiport Surgery

Momentis Surgical has secured 510(k) clearance from the U.S. Food and Drug Administration for a multiport version of its Anovo Surgical...

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Lupin Secures U.S. FDA Tentative Approval for Enzalutamide Tablets

Lupin Limited (Lupin) the Mumbai, India based global pharma major earlier this week had announced that the company has received tentative approval from the...

Mayo Clinic Finds Common Surgical Drug Could Reduce Risk of Liver Failure

Researchers at Mayo Clinic and Michigan State University have uncovered a potentially life-saving application for tranexamic acid, a widely used clot-preserving medication, in the context of...

Shilpa Biologicals Activates GMP-Certified ADC Manufacturing Hub in Dharwad, India

Shilpa Biologicals, the biologics arm of Raichur-based Shilpa Medicare Ltd., has formally activated its antibody–drug conjugate (ADC) drug substance manufacturing facility in Dharwad, India. The plant is currently...

New Hope for Thyroid Eye Disease Treatment as FDA Approves Lumvoa

Waltham-based Viridian Therapeutics (Nasdaq: VRDN) has secured U.S. Food and Drug Administration clearance for Lumvoa™ (veligrotug-vvze), marking the company's debut as a commercial-stage biotech and...

Government Proposes Faster Regulatory Approvals for Medical Device Manufacturers

India's Ministry of Health and Family Welfare has published draft amendments to the Medical Devices Rules, 2017, via G.S.R. 515(E) in the Extraordinary Gazette...

No free passes: FDA tightens rule against Foreign Tobacco Manufactures

The U.S. Food and Drug Administration (FDA)  issued a proposed rule aimed at strengthening oversight of foreign tobacco product manufacturers and blocking illegal products...